Alnylam Pharmaceuticals, Inc. (0HD2.L)

USD 261.0

(2.96%)

Eps Summary of Alnylam Pharmaceuticals, Inc.

  • Alnylam Pharmaceuticals, Inc.'s latest annual eps in 2023 was -3.52 USD , up 62.15% from previous year.
  • Alnylam Pharmaceuticals, Inc.'s latest quarterly eps in 2024 Q1 was -0.52 USD , up 52.73% from previous quarter.
  • Alnylam Pharmaceuticals, Inc. reported an annual eps of -9.30 USD in 2022, down -29.17% from previous year.
  • Alnylam Pharmaceuticals, Inc. reported an annual eps of -7.20 USD in 2021, up 3.49% from previous year.
  • Alnylam Pharmaceuticals, Inc. reported a quarterly eps of -0.52 USD for 2024 Q1, up 52.73% from previous quarter.
  • Alnylam Pharmaceuticals, Inc. reported a quarterly eps of -0.13 USD for 2024 Q2, up 75.0% from previous quarter.

Annual Eps Chart of Alnylam Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Eps of Alnylam Pharmaceuticals, Inc. (2023 - 2012)

Year Eps Eps Growth
2023 -3.52 USD 62.15%
2022 -9.30 USD -29.17%
2021 -7.20 USD 3.49%
2020 -7.46 USD 8.01%
2019 -8.11 USD -7.13%
2018 -7.57 USD -39.67%
2017 -5.42 USD -13.15%
2016 -4.79 USD -38.84%
2015 -3.45 USD 28.87%
2014 -4.85 USD -234.48%
2013 -1.45 USD 31.28%
2012 -2.11 USD 0.0%

Peer Eps Comparison of Alnylam Pharmaceuticals, Inc.

Name Eps Eps Difference
uniQure N.V. -6.47 USD 45.595%
Abeona Therapeutics Inc. -2.53 USD -39.13%
Aclaris Therapeutics, Inc. -1.27 USD -177.165%
Agios Pharmaceuticals, Inc. -6.33 USD 44.392%
Atara Biotherapeutics, Inc. -65.18 USD 94.6%
Cara Therapeutics, Inc. -2.19 USD -60.731%
Imunon, Inc. -2.16 USD -62.963%
Dynavax Technologies Corporation -0.05 USD -6996.774%
Editas Medicine, Inc. -2.02 USD -74.257%
FibroGen, Inc. -2.92 USD -20.548%
Iovance Biotherapeutics, Inc. -1.89 USD -86.243%
Kala Pharmaceuticals, Inc. -17.35 USD 79.712%
Neurocrine Biosciences, Inc. 2.56 USD 237.5%
Sarepta Therapeutics, Inc. -5.80 USD 39.31%
Supernus Pharmaceuticals, Inc. 0.02 USD 14705.809%
Verastem, Inc. -3.96 USD 11.111%
Zoetis Inc. 5.08 USD 169.291%
Vertex Pharmaceuticals Incorporated 14.05 USD 125.053%
Sangamo Therapeutics, Inc. -1.48 USD -137.838%
Homology Medicines, Inc. -7.41 USD 52.497%
Nektar Therapeutics -1.45 USD -142.759%
Viking Therapeutics, Inc. -0.91 USD -286.813%
Unity Biotechnology, Inc. -2.70 USD -30.37%
Perrigo Company plc -0.09 USD -3648.669%
Esperion Therapeutics, Inc. -2.03 USD -73.399%
Walgreens Boots Alliance, Inc. -10.01 USD 64.835%
Illumina, Inc. -7.35 USD 52.109%
Thermo Fisher Scientific Inc. 15.53 USD 122.666%
IQVIA Holdings Inc. 7.39 USD 147.632%
Heron Therapeutics, Inc. -0.80 USD -340.0%
Waters Corporation 10.87 USD 132.383%
Biogen Inc. 8.02 USD 143.89%
Evolus, Inc. -1.08 USD -225.926%
Adicet Bio, Inc. -3.31 USD -6.344%
bluebird bio, Inc. -1.93 USD -82.383%
Geron Corporation -0.32 USD -1000.0%
Amicus Therapeutics, Inc. -0.51 USD -590.196%
Myriad Genetics, Inc. -1.39 USD -153.237%
Intellia Therapeutics, Inc. -5.42 USD 35.055%
Mettler-Toledo International Inc. 36.10 USD 109.751%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 65.858%
BioMarin Pharmaceutical Inc. 0.89 USD 495.506%
Regeneron Pharmaceuticals, Inc. 37.05 USD 109.501%
Agilent Technologies, Inc. 4.22 USD 183.412%
OPKO Health, Inc. -0.25 USD -1308.0%
Exelixis, Inc. 0.65 USD 641.538%
Corcept Therapeutics Incorporated 1.02 USD 445.098%
Anavex Life Sciences Corp. -0.60 USD -486.667%
Axsome Therapeutics, Inc. -5.27 USD 33.207%
Ionis Pharmaceuticals, Inc. -2.56 USD -37.5%
Halozyme Therapeutics, Inc. 2.13 USD 265.258%
Blueprint Medicines Corporation -8.37 USD 57.945%
Insmed Incorporated -5.34 USD 34.082%
TG Therapeutics, Inc. 0.09 USD 4041.769%
Incyte Corporation 2.67 USD 231.835%
Emergent BioSolutions Inc. -14.85 USD 76.296%